{"transactions":[{"id":833870,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-19T20:34:31.000Z","date":"2026-03-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":4252,"price":56.05,"value":238324.6,"ownership":{"direct":true},"balance_after":214635,"source":{"system":"sec-edgar","filing":"0001628280-26-019847","document":"wk-form4_1773952468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019847/wk-form4_1773952468.xml","form_type":"4"}},{"id":839159,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":89200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter."}],"balance_after":89200,"derivative":{"exercise_price":57.43,"exercise_date":"2027-03-16","expiration_date":"2036-03-15","underlying":"Common Stock","underlying_shares":89200},"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":839158,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-16","kind":"grant","planned":false,"acquired":true,"shares":62440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 16, 2026. Price not applicable."}],"balance_after":218887,"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":839157,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-18T00:43:06.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":2941,"price":58.51,"value":172077.91,"ownership":{"direct":true},"balance_after":156447,"source":{"system":"sec-edgar","filing":"0001628280-26-019006","document":"wk-form4_1773794583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026019006/wk-form4_1773794583.xml","form_type":"4"}},{"id":984090,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-02T23:29:07.000Z","date":"2025-12-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":16570,"price":55.03,"value":911847.1,"ownership":{"direct":true},"balance_after":159388,"source":{"system":"sec-edgar","filing":"0001628280-25-054856","document":"wk-form4_1764718145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828025054856/wk-form4_1764718145.xml","form_type":"4"}},{"id":984089,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-02T23:29:07.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":375,"price":54.137,"value":20301.375,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":175958,"source":{"system":"sec-edgar","filing":"0001628280-25-054856","document":"wk-form4_1764718145.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828025054856/wk-form4_1764718145.xml","form_type":"4"}},{"id":1201336,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":61750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter."}],"balance_after":61750,"derivative":{"exercise_price":71.55,"exercise_date":"2026-03-17","expiration_date":"2035-03-16","underlying":"Common Stock","underlying_shares":61750},"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1201335,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":44360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 17, 2025. Price not applicable."}],"balance_after":175583,"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1201334,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-03-18T22:17:35.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2933,"price":69.44,"value":203667.52,"ownership":{"direct":true},"balance_after":131223,"source":{"system":"sec-edgar","filing":"0001048477-25-000027","document":"wk-form4_1742336248.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847725000027/wk-form4_1742336248.xml","form_type":"4"}},{"id":1345743,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-03T23:15:02.000Z","date":"2024-11-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":14295,"price":66.03,"value":943898.85,"ownership":{"direct":true},"balance_after":134156,"source":{"system":"sec-edgar","filing":"0001048477-24-000156","document":"wk-form4_1733267696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000156/wk-form4_1733267696.xml","form_type":"4"}},{"id":1345742,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-12-03T23:15:02.000Z","date":"2024-10-31","kind":"grant","planned":false,"acquired":true,"shares":300,"price":56.007,"value":16802.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Represents the shares acquired by the reporting person on October 31, 2024, pursuant to the issuer's Employee Stock Purchase Plan."}],"balance_after":148451,"source":{"system":"sec-edgar","filing":"0001048477-24-000156","document":"wk-form4_1733267696.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000156/wk-form4_1733267696.xml","form_type":"4"}},{"id":1570136,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2024-03-20T00:42:54.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":44050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter."}],"balance_after":44050,"derivative":{"exercise_price":83.87,"exercise_date":"2025-03-15","expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":44050},"source":{"system":"sec-edgar","filing":"0001048477-24-000040","document":"wk-form4_1710895361.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000040/wk-form4_1710895361.xml","form_type":"4"}},{"id":1570135,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-20T00:42:54.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":32780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted March 15, 2024. Price not applicable."}],"balance_after":148151,"source":{"system":"sec-edgar","filing":"0001048477-24-000040","document":"wk-form4_1710895361.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847724000040/wk-form4_1710895361.xml","form_type":"4"}},{"id":1722389,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy Common Stock)","published_at":"2023-12-05T22:13:53.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":150529,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option grant vests 12/48th on December 1, 2024 and 1/48th on the 1st day of each month thereafter."}],"balance_after":150529,"derivative":{"exercise_price":92.42,"exercise_date":"2024-12-01","expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":150529},"source":{"system":"sec-edgar","filing":"0001048477-23-000055","document":"wk-form4_1701814423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000055/wk-form4_1701814423.xml","form_type":"4"}},{"id":1722388,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-05T22:13:53.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":47332,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on December 1, 2023. Price not applicable."}],"balance_after":115371,"source":{"system":"sec-edgar","filing":"0001048477-23-000055","document":"wk-form4_1701814423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000055/wk-form4_1701814423.xml","form_type":"4"}},{"id":1722387,"issuer":{"id":2404,"kind":"organization","name":"BIOMARIN PHARMACEUTICAL INC","symbol":"BMRN"},"owners":[{"id":57236,"kind":"person","name":"Hardy Alexander","position":1,"cik":"0002001910","reported_name":"Hardy Alexander","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-05T22:13:53.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":68039,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units granted on December 1, 2023. Price not applicable."}],"balance_after":68039,"source":{"system":"sec-edgar","filing":"0001048477-23-000055","document":"wk-form4_1701814423.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000104847723000055/wk-form4_1701814423.xml","form_type":"4"}}]}